Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) — Denver, Colorado

Public research footprint of Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

Lymphoma · Multiple Myeloma · Estrogen Receptor-Positive Breast Cancer · B-cell Chronic Lymphocytic Leukemia

Recently updated registry entries

NCT06745024 — Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone… (Active Not Recruiting)
NCT02332850 — Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or… (Completed)
NCT02649790 — Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.